Page last updated: 2024-11-11

taxuyunnanine c

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID5321771
CHEMBL ID436993
CHEBI ID15208
MeSH IDM0478807

Synonyms (7)

Synonym
CHEBI:15208 ,
taxa-4(20),11-diene-2alpha,5alpha,10beta,14beta-tetrayl tetraacetate
taxuyunnanin c
taxuyunnanine c
CHEMBL436993
[(1s,2s,3s,5s,8s,10s,14s)-2,10,14-triacetyloxy-8,12,15,15-tetramethyl-4-methylidene-5-tricyclo[9.3.1.03,8]pentadec-11-enyl] acetate
Q27109022
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
taxane diterpenoid
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (12)

Assay IDTitleYearJournalArticle
AID399200Reversal of multidrug resistance in human 2780AD cells assessed as [3H]vincristine accumulation at 1 ug/mL after 2 hrs relative to verapamil2004Journal of natural products, Jan, Volume: 67, Issue:1
Production of biologically active taxoids by a callus culture of Taxus cuspidata.
AID399201Reversal of multidrug resistance in human 2780AD cells assessed as [3H]vincristine accumulation at 10 ug/mL after 2 hrs relative to verapamil2004Journal of natural products, Jan, Volume: 67, Issue:1
Production of biologically active taxoids by a callus culture of Taxus cuspidata.
AID307735Growth inhibition of human HepG2 cells2007Bioorganic & medicinal chemistry letters, Jul-01, Volume: 17, Issue:13
Synthesis and structure-activity relationships of taxuyunnanine C derivatives as multidrug resistance modulator in MDR cancer cells.
AID399197Reversal of multidrug resistance in human 2780AD cells assessed as [3H]vincristine accumulation at 1 ug/mL after 2 hrs relative to control2004Journal of natural products, Jan, Volume: 67, Issue:1
Production of biologically active taxoids by a callus culture of Taxus cuspidata.
AID307733Growth inhibition of human WI38 cells2007Bioorganic & medicinal chemistry letters, Jul-01, Volume: 17, Issue:13
Synthesis and structure-activity relationships of taxuyunnanine C derivatives as multidrug resistance modulator in MDR cancer cells.
AID307734Growth inhibition of human VA13 cells2007Bioorganic & medicinal chemistry letters, Jul-01, Volume: 17, Issue:13
Synthesis and structure-activity relationships of taxuyunnanine C derivatives as multidrug resistance modulator in MDR cancer cells.
AID399198Reversal of multidrug resistance in human 2780AD cells assessed as [3H]vincristine accumulation at 10 ug/mL after 2 hrs relative to control2004Journal of natural products, Jan, Volume: 67, Issue:1
Production of biologically active taxoids by a callus culture of Taxus cuspidata.
AID399196Reversal of multidrug resistance in human 2780AD cells assessed as [3H]vincristine accumulation at 0.1 ug/mL after 2 hrs relative to control2004Journal of natural products, Jan, Volume: 67, Issue:1
Production of biologically active taxoids by a callus culture of Taxus cuspidata.
AID399199Reversal of multidrug resistance in human 2780AD cells assessed as [3H]vincristine accumulation at 0.1 ug/mL after 2 hrs relative to verapamil2004Journal of natural products, Jan, Volume: 67, Issue:1
Production of biologically active taxoids by a callus culture of Taxus cuspidata.
AID307732Inhibition of Pgp in multidrug-resistant human 2780AD cells assessed as calcein accumulation at 25 ug/mL relative to control2007Bioorganic & medicinal chemistry letters, Jul-01, Volume: 17, Issue:13
Synthesis and structure-activity relationships of taxuyunnanine C derivatives as multidrug resistance modulator in MDR cancer cells.
AID307731Inhibition of Pgp in multidrug-resistant human 2780AD cells assessed as calcein accumulation at 2.5 ug/mL relative to control2007Bioorganic & medicinal chemistry letters, Jul-01, Volume: 17, Issue:13
Synthesis and structure-activity relationships of taxuyunnanine C derivatives as multidrug resistance modulator in MDR cancer cells.
AID307730Inhibition of Pgp in multidrug-resistant human 2780AD cells assessed as calcein accumulation at 0.25 ug/mL relative to control2007Bioorganic & medicinal chemistry letters, Jul-01, Volume: 17, Issue:13
Synthesis and structure-activity relationships of taxuyunnanine C derivatives as multidrug resistance modulator in MDR cancer cells.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's9 (60.00)29.6817
2010's6 (40.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.54

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.54 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index4.37 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.54)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]